MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 14.11.2025
ENDRA Life Sciences EV 2011-2026 | NDRA
EV Jährlich ENDRA Life Sciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 864 K | -1.74 M | 8.81 M | -6.46 M | 30.8 M | 7.48 M | 4.32 M | 4.62 M | 1.24 M | 236 K | 97.6 K | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 30.8 M | -6.46 M | 4.57 M |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Brainsway Ltd.
BWAY
|
223 M | $ 23.11 | 0.09 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
433 M | $ 23.3 | - | $ 251 M |  China |
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M |  USA |
 |
Co-Diagnostics
CODX
|
29.3 M | $ 6.19 | - | $ 182 M | USA |
 |
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
665 M | $ 39.34 | - | $ 1.09 B | USA |
 |
BioNano Genomics
BNGO
|
35.7 M | $ 1.58 | - | $ 2.01 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M |  Britain |
 |
DexCom
DXCM
|
52.4 B | $ 67.4 | - | $ 26 B | USA |
 |
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | Israel |
 |
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | China |
 |
Guardant Health
GH
|
6.94 B | $ 110.17 | - | $ 13.5 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
644 M | $ 17.13 | - | $ 921 M | USA |
 |
Danaher Corporation
DHR
|
150 B | $ 238.37 | - | $ 174 B | USA |
 |
Celcuity
CELC
|
506 M | $ 107.51 | - | $ 4.24 B | USA |
 |
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
DarioHealth Corp.
DRIO
|
6.61 M | $ 12.16 | -5.74 % | $ 345 M | Israel |
 |
Anixa Biosciences
ANIX
|
1.5 M | $ 3.38 | -1.17 % | $ 108 K | USA |
 |
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | USA |
 |
Illumina
ILMN
|
15.3 B | $ 141.07 | - | $ 22.4 B | USA |
 |
Exact Sciences Corporation
EXAS
|
12.2 B | $ 102.11 | 0.32 % | $ 18.9 B | USA |
 |
Fulgent Genetics
FLGT
|
502 M | $ 27.85 | -0.14 % | $ 842 M | USA |
 |
Aspira Women's Health
AWH
|
42.8 M | - | -6.19 % | $ 10.5 M | USA |
 |
Lantheus Holdings
LNTH
|
6.44 B | $ 67.56 | - | $ 4.68 B | USA |
 |
Charles River Laboratories International
CRL
|
12.4 B | $ 220.91 | -0.08 % | $ 11.4 B | USA |
 |
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | USA |
 |
Mettler-Toledo International
MTD
|
33.2 B | $ 1 485.12 | -0.02 % | $ 31.5 B |  Schweiz |
 |
IQVIA Holdings
IQV
|
54.8 B | $ 242.41 | -0.32 % | $ 43.9 B | USA |
 |
Neogen Corporation
NEOG
|
2.26 B | $ 9.62 | - | $ 2.09 B | USA |
 |
National Research Corporation
NRC
|
1.08 B | $ 19.72 | 1.18 % | $ 484 M | USA |
 |
Natera
NTRA
|
5.53 B | $ 234.31 | - | $ 23.1 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
18.5 B | $ 174.44 | -0.01 % | $ 19.4 B | USA |
|
Biodesix
BDSX
|
142 M | $ 5.46 | - | $ 708 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
29.9 B | $ 251.81 | - | $ 21.1 B | USA |
 |
ICON Public Limited Company
ICLR
|
26.4 B | $ 181.38 | -3.63 % | $ 15 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
39.1 B | $ 713.35 | 0.13 % | $ 58.8 B | USA |
 |
Pacific Biosciences of California
PACB
|
2.28 B | $ 1.94 | - | $ 492 M | USA |
 |
Agilent Technologies
A
|
45.8 B | $ 148.52 | 1.89 % | $ 45.2 B | USA |
 |
Biomerica
BMRA
|
6.63 M | $ 2.73 | - | $ 6.27 M | USA |
 |
Bioventus
BVS
|
904 M | $ 8.03 | 0.37 % | $ 503 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
14.5 B | $ 29.58 | - | $ 20 B |  Niderland |